BIOBANK Renal Transplantation University Hospitals Leuven

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

renal transplant recipients/donors

Disqualifiers

none

Trial population

All donors and recipients of a kidney transplant at the University Hospitals Leuven

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

5,000 Participants
are grouped into 1 trial group
Group A: renal allograft donors and recipients

Trial outcomes

Primary outcomes

1

Renal allograft survival

Time frame
50 years after transplantation

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.